Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paracetamol for Borderline PDA in Preterm Neonates
NCT02819414Phase 2Unknown
- Sponsor
- Shaare Zedek Medical Center
- Start
- Jun 2016
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of acetaminophen in patent ductus arteriosus (PDA) (2 arms), sponsored by Shaare Zedek Medical Center. Primary endpoint: Composite outcome of death or severe morbidity chronic lung disease [CLD]. Status: unknown.
02
Drugs
acetaminophen
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on NCT02819414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02819414.